Intelligent manufacturing to promote the transformation and upgrading of the Chinese medicine industry, improve efficiency and quality

"
Pharmaceutical Network Industry Dynamic" Since 2020, Chinese medicine has received extensive attention and market re-acceptance, the industry ushered in the opportunity for developmentAt the same time,exports of Chinese herbal medicinesand traditional Chinese medicines increased significantlyChina's foreign trade data for the first quarter of 2020 show that in the first quarter of 2020, China's exports of Chinese herbal medicines and traditional Chinese medicines were close to 33,000 tons, up 10.3% YoY, while exports amounted to 1.88 billion yuan, up 3.2% YoYwith the advancement of the big health strategy, as well as the aging of people, health care awareness, consumption level swellsThe traditional Chinese medicine industry also faces the need to expand production capacity and technological upgradingAnd intelligent manufacturing will play an important role in ittake the fully automatic digital Chinese medicine extraction workshop project of a pharmaceutical company as an example, the project through information technology, to establish an integrated control system of production and marketing, to achieve the automation of production process and digital traceability of product qualityAccording to the pharmaceutical shop workshop staff described, after the feeding, the staff only need to set the temperature, time, water, pressure and other parameters, and real-time observation can beAt present, the workshop can achieve annual processing of 3700 tons of medicinal herbs, the realization of the output value of the finished product of about 3 billion yuan, compared with the original production workshop, intelligent workshop production capacity increased by 10 times, product production cycle and energy consumption have been shortened or reduced, the key production process numerical control rate of 95%, to achieve a significant increase in production capacity, improve quality, reduce costs and improve the chinese medicine extraction production information and intelligent effectthe author notes that in recent years, many pharmaceutical companies are planning or promoting the construction project of Chinese medicine extractionFor example, Renhe Pharmaceuticals recently announced that the company intends to use its own funds to invest in the Ming Yueren and mineral water plant projects and Chinese medicine pre-treatment and extraction projectsAmong them, for the construction of Chinese medicine pretreatment and extraction projects, the company believes that it is conducive to the company to improve the pre-treatment and extraction efficiency of Chinese medicine, improve the company's environmental protection propertiesYongtai Science and Technology Annual Report disclosed that Yongtai hand-in-hand annual output of 4340 tons ofraw materialsand 600 million chinese medicine extraction construction project is currently under going on to install and commission equipmentThe company recently said on the interactive platform, Yongtai hand-held an annual output of 4340 tons of raw materials and 600 million chinese medicine extraction construction project is currently advancing steadily, the company will promote the project as soon as possible to put into operationThe 27th meeting of the 6th Board of Directors was held on November 15, 2019, to consider and approve the Bill on the Investment of Wholly Owned Subsidiaries to Build the Industrialization project of Modern Chinese MedicineThe total investment of the project is estimated at RMB 5,034 millionOf these, 4,832 million yuan was invested in constructionThe construction period of 3 years, the construction investment plan in the construction period, the investment ratio of 40% in the first year, 40% in the second year, 20% in the third yearAfter the completion of the project, it is expected to achieve annual sales revenue of about 5.770 billion yuan, net profit of about 2.690 billion yuan, investment payback period of about 4.96 yearscompany said that the project construction is due to the company's future strategic considerations, in line with the company's main business development strategy, not only conducive to further improve the company's chinese medicine, health industry production base strategic layout, expand the production capacity of Chinese medicine tablets, Chinese medicine tablets, health care products, but also for the future development of the company's Chinese medicine formula particles, Chinese medicineextractsbusiness to do a good job of production capacity reserves, so as to optimize the company's product structure, for the company's core competitiveness is of great significanceindustry believes that the intelligent manufacturing of chinese medicine industry is of great significance, not only to promote the transformation and upgrading of the traditional Chinese medicine industry, improve efficiency and quality, but also to inherit the good value of Chinese medicine, to help Chinese medicine to the international stage